Leaflet OVITRELLE 250mcg powder+solvent for injection


Indicated for: infertility

Route of administration: injectable

Substance: chorionic gonadotrophin alpha (gonadotropin)

ATC: G03GA08 (Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants)

Chorionic gonadotropin alfa is a synthetic form of the human hormone used in the treatment of infertility, especially in women undergoing assisted reproduction procedures. This medication stimulates the maturation of eggs and triggers ovulation, increasing the chances of success for in vitro fertilization or similar techniques.

It is administered by subcutaneous injection, as directed by your specialist. The dose and timing are carefully determined to synchronize the treatment with other medications used for ovarian stimulation. Close monitoring is essential to prevent complications.

Side effects may include reactions at the injection site, abdominal pain, nausea, headache, or allergic reactions. In rare cases, ovarian hyperstimulation syndrome may occur, a serious complication that requires prompt medical intervention. Any unusual symptoms should be reported to your doctor immediately.

Chorionic gonadotropin alfa is a modern and effective medication for supporting fertility, but its use requires strict medical supervision. Follow the instructions carefully and do not change the treatment without your doctor's approval to ensure safety and effectiveness.

General data about OVITRELLE 250mcg

  • Substance: chorionic gonadotrophin alpha
  • Date of last drug list: 01-07-2013
  • Commercial code: W59315004
  • Concentration: 250mcg
  • Pharmaceutical form: powder+solvent for injection
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for chorionic gonadotrophin alpha

  • 250mcg
  • 250mcg/0.5ml